Table 2 Outcomes by duration of treatment (≥5 days vs. no treatment)
Characteristic | All patientsa (n = 184) | Treatment ≥5 days (n = 140) | No treatment (n = 32) | p-value |
|---|---|---|---|---|
Primary outcome | ||||
Non-resolved infection | 30 (16%) | 29 (21%) | 0 (0%) | 0.010 |
Septic thrombosis | 25 (14%) | 24 (17%) | 0 (0%) | 0.025 |
Prolonged bacteremia | 4 (2%) | 4 (3%) | 0 (0%) | 0.751 |
Abscess | 2 (1%) | 2 (1%) | 0 (0%) | 1.000 |
Secondary oucomes | ||||
Recurrence (bacteremia) | 8 (4%) | 8 (6%) | 0 (0%) | 0.358 |
ICU admission | 18 (10%) | 15 (11%) | 1 (3%) | 0.111 |
Days to discharge, median (IQR) | 13 (7–21) | 15 (8–21) | 11.5 (5–32) | 0.253 |
Hospital mortality | 22 (12%) | 12 (9%) | 6 (19%) | 0.169 |
Mortality during follow-up | 38 (21%) | 26 (19%) | 8 (25%) | 0.563 |
Side effects | 3 (2%) | 3 (2%) | ||
Days of follow-up, mean (±SD) | 234.2 (±155.1) | 241.2 (±152.3) | 232.4 (±161.2) | |